Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes (T2D). Here, we describe the in vitro characteristics and anti-diabetic in vivo efficacy of the novel GLP-1RA GL0034.
In vivo and in vitro characterisation of GL0034, a novel long-acting GLP-1 receptor agonist
Piemonti, Lorenzo;
2022-01-01
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes (T2D). Here, we describe the in vitro characteristics and anti-diabetic in vivo efficacy of the novel GLP-1RA GL0034.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
